The drive to identify genetic factors influencing left ventricular mass responses to antihypertensive treatment.
Fagard
Robert H
RH
Kuznetsova
Tatiana
T
D000808:Angiotensinogen / Q000235:genetics; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D019405:Cytochrome P-450 CYP11B2 / Q000235:genetics; D005819:Genetic Markers; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D011110:Polymorphism, Genetic; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000235:genetics; D012084:Renin-Angiotensin System / Q000235:genetics; D012307:Risk Factors
D000959:Antihypertensive Agents; D005819:Genetic Markers; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; D000808:Angiotensinogen; D019405:Cytochrome P-450 CYP11B2; D007703:Peptidyl-Dipeptidase A